A tamoxifen inducible knock-in allele for investigation of E2A function

BMC Developmental Biology

Volumn 9, Issue 1, 2009, Pages

  Jones, Mary E ^a   Kondo, Motonari ^a   Zhuang, Yuan ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; TAMOXIFEN; TRANSCRIPTION FACTOR E2A; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; HYBRID PROTEIN; TCF3 PROTEIN, MOUSE;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; BONE MARROW CELL; CONTROLLED STUDY; EX VIVO STUDY; GENE; GENE INDUCTION; GENE INSERTION; MOUSE; NONHUMAN; PROTEIN FUNCTION; PROTEIN INDUCTION; TCFE2A GENE; ANIMAL; B LYMPHOCYTE; CELL CULTURE; DRUG EFFECT; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; GENETICS; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; PROTEIN BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALIA; MAMMALIA; MUS;

ALLELES; ANIMALS; B-LYMPHOCYTES; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BLOTTING, WESTERN; CELLS, CULTURED; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FLOW CYTOMETRY; MICE; MICE, MUTANT STRAINS; PROTEIN BINDING; RECEPTORS, ESTROGEN; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TAMOXIFEN;

EID: 70449113023     PISSN: None     EISSN: 1471213X     Source Type: Journal    
DOI: 10.1186/1471-213X-9-51     Document Type: Article

References (47)

1. Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. ME Massari C Murre, Mol Cell Biol 2000 20 429 40 10.1128/MCB.20.2. 429-440.2000 10611221
2. Helix-loop-helix proteins and lymphocyte development. C Murre, Nat Immunol 2005 6 1079 86 10.1038/ni1260 16239924
3. New insights into E-protein function in lymphocyte development. A Lazorchak ME Jones Y Zhuang, Trends Immunol 2005 26 334 8 10.1016/j.it.2005.03. 011 15922950
4. B-lymphocyte development is regulated by the combined dosage of three basic helix-loop-helix genes, E2A, E2-2, and HEB. Y Zhuang P Cheng H Weintraub, Mol Cell Biol 1996 16 2898 905 8649400
5. A heterodimer of HEB and an E12-related protein interacts with the CD4 enhancer and regulates its activity in T-cell lines. S Sawada DR Littman, Mol Cell Biol 1993 13 5620 8 8355705
6. Functions of E2A-HEB heterodimers in T-cell development revealed by a dominant negative mutation of HEB. RJ Barndt M Dai Y Zhuang, Mol Cell Biol 2000 20 6677 85 10.1128/MCB.20.18.6677-6685.2000 10958665
7. Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. B Cisse ML Caton M Lehner T Maeda S Scheu R Locksley D Holmberg C Zweier NS den Hollander SG Kant, et al. Cell 2008 135 37 48 10.1016/j.cell.2008.09.016 18854153
8. Development of human plasmacytoid dendritic cells depends on the combined action of the basic helix-loop-helix factor E2-2 and the Ets factor Spi-B. M Nagasawa H Schmidlin MG Hazekamp R Schotte B Blom, Eur J Immunol 2008 38 2389 400 10.1002/eji.200838470 18792017
9. Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. C Murre PS McCaw H Vaessin M Caudy LY Jan YN Jan CV Cabrera JN Buskin SD Hauschka AB Lassar, et al. Cell 1989 58 537 44 10.1016/0092-8674(89)90434-0 2503252
10. Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo. AB Lassar RL Davis WE Wright T Kadesch C Murre A Voronova D Baltimore H Weintraub, Cell 1991 66 305 15 10.1016/0092-8674(91)90620-E 1649701
11. Tissue-specific regulation of the insulin gene by a novel basic helix-loop-helix transcription factor. FJ Naya CM Stellrecht MJ Tsai, Genes Dev 1995 9 1009 19 10.1101/gad.9.8.1009 7774807
12. Ligand-activated site-specific recombination in mice. R Feil J Brocard B Mascrez M LeMeur D Metzger P Chambon, Proc Natl Acad Sci USA 1996 93 10887 90 10.1073/pnas.93.20.10887 8855277
13. Temporally and spatially regulated somatic mutagenesis in mice. F Schwenk R Kuhn PO Angrand K Rajewsky AF Stewart, Nucleic Acids Res 1998 26 1427 32 10.1093/nar/26.6.1427 9490788
14. A highly efficient ligand-regulated Cre recombinase mouse line shows that LoxP recombination is position dependent. M Vooijs J Jonkers A Berns, EMBO Rep 2001 2 292 7 10.1093/embo-reports/kve064 11306549
15. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse. S Hayashi AP McMahon, Dev Biol 2002 244 305 18 10.1006/dbio.2002.0597 11944939
16. Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression. DA Bergstrom BH Penn A Strand RL Perry MA Rudnicki SJ Tapscott, Mol Cell 2002 9 587 600 10.1016/S1097-2765(02)00481-1 11931766
17. Cell-lineage regulated myogenesis for dystrophin replacement: a novel therapeutic approach for treatment of muscular dystrophy. E Kimura JJ Han S Li B Fall J Ra M Haraguchi SJ Tapscott JS Chamberlain, Hum Mol Genet 2008 17 2507 17 10.1093/hmg/ddn151 18511457
18. The helix-loop-helix gene E2A is required for B cell formation. Y Zhuang P Soriano H Weintraub, Cell 1994 79 875 84 10.1016/0092-8674(94)90076-0 8001124
19. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. G Bain EC Maandag DJ Izon D Amsen AM Kruisbeek BC Weintraub I Krop MS Schlissel AJ Feeney M van Roon, et al. Cell 1994 79 885 92 10.1016/0092-8674(94)90077-9 8001125
20. Promotion of cell cycle progression by basic helix-loop-helix E2A. F Zhao A Vilardi RJ Neely JK Choi, Mol Cell Biol 2001 21 6346 57 10.1128/MCB.21.18. 6346-6357.2001 11509675
21. Regulation of E2A gene expression in B-lymphocyte development. Y Zhuang A Jackson L Pan K Shen M Dai, Mol Immunol 2004 40 1165 77 10.1016/j.molimm.2003. 11.031 15104122
22. Functional replacement of the mouse E2A gene with a human HEB cDNA. Y Zhuang RJ Barndt L Pan R Kelley M Dai, Mol Cell Biol 1998 18 3340 9 9584174
23. B cell development pathways. RR Hardy K Hayakawa, Annu Rev Immunol 2001 19 595 621 10.1146/annurev.immunol.19.1.595 11244048
24. Both E12 and E47 allow commitment to the B cell lineage. G Bain EC Robanus Maandag HP te Riele AJ Feeney A Sheehy M Schlissel SA Shinton RR Hardy C Murre, Immunity 1997 6 145 54 10.1016/S1074-7613(00)80421-5 9047236
25. Early B cell factor promotes B lymphopoiesis with reduced interleukin 7 responsiveness in the absence of E2A. CS Seet RL Brumbaugh BL Kee, J Exp Med 2004 199 1689 700 10.1084/jem.20032202 15210745
26. Gradient of E2A activity in B-cell development. S Herblot PD Aplan T Hoang, Mol Cell Biol 2002 22 886 900 10.1128/MCB.22.3.886-900.2002 11784864
27. E47 is required for V(D)J recombinase activity in common lymphoid progenitors. L Borghesi J Aites S Nelson P Lefterov P James R Gerstein, J Exp Med 2005 202 1669 77 10.1084/jem.20051190 16365147
28. B-lineage differentiation in normal and transformed cells and the microenvironment that supports it. N Rosenberg PW Kincade, Curr Opin Immunol 1994 6 203 11 10.1016/0952-7915(94)90093-0 8011205
29. Pax5 determines the identity of B cells from the beginning to the end of B-lymphopoiesis. SL Nutt D Eberhard M Horcher AG Rolink M Busslinger, Int Rev Immunol 2001 20 65 82 11342298
30. Systematic design and testing of nested (RT-)PCR primers for specific amplification of mouse rearranged/expressed immunoglobulin variable region genes from small number of B cells. S Rohatgi P Ganju D Sehgal, J Immunol Methods 2008 339 205 19 10.1016/j.jim.2008.09.017 18926828
31. E-proteins directly regulate expression of activation-induced deaminase in mature B cells. CE Sayegh MW Quong Y Agata C Murre, Nat Immunol 2003 4 586 93 10.1038/ni923 12717431
32. Differential functions for the transcription factor E2A in positive and negative gene regulation in pre-B lymphocytes. S Greenbaum AS Lazorchak Y Zhuang, J Biol Chem 2004 279 45028 35 10.1074/jbc.M400061200 15310760
33. E2A and IRF-4/Pip promote chromatin modification and transcription of the immunoglobulin kappa locus in pre-B cells. AS Lazorchak MS Schlissel Y Zhuang, Mol Cell Biol 2006 26 810 21 10.1128/MCB.26.3.810-821.2006 16428437
34. Long-term cultured E2A-deficient hematopoietic progenitor cells are pluripotent. T Ikawa H Kawamoto LY Wright C Murre, Immunity 2004 20 349 60 10.1016/S1074-7613(04)00049-4 15030778
35. Ectopic expression of E47 or E12 promotes the death of E2A-deficient lymphomas. I Engel C Murre, Proc Natl Acad Sci USA 1999 96 996 1001 10.1073/pnas.96.3.996 9927682
36. E2A proteins promote development of lymphoid-primed multipotent progenitors. S Dias R Mansson S Gurbuxani M Sigvardsson BL Kee, Immunity 2008 29 217 27 10.1016/j.immuni.2008.05.015 18674933
37. E2A proteins maintain the hematopoietic stem cell pool and promote the maturation of myelolymphoid and myeloerythroid progenitors. CL Semerad EM Mercer MA Inlay IL Weissman C Murre, Proc Natl Acad Sci USA 2009 106 1930 5 10.1073/pnas.0808866106 19181846
38. Important roles for E protein binding sites within the immunoglobulin kappa chain intronic enhancer in activating Vkappa Jkappa rearrangement. MA Inlay H Tian T Lin Y Xu, J Exp Med 2004 200 1205 11 10.1084/jem.20041135 15504821
39. Receptor editing and marginal zone B cell development are regulated by the helix-loop-helix protein, E2A. MW Quong A Martensson AW Langerak RR Rivera D Nemazee C Murre, J Exp Med 2004 199 1101 12 10.1084/jem.20031180 15078898
40. Regulation of the helix-loop-helix proteins, E2A and Id3, by the Ras-ERK MAPK cascade. G Bain CB Cravatt C Loomans J Alberola-Ila SM Hedrick C Murre, Nat Immunol 2001 2 165 71 10.1038/84273 11175815
41. E2A promotes the survival of precursor and mature B lymphocytes. AS Lazorchak J Wojciechowski M Dai Y Zhuang, J Immunol 2006 177 2495 504 16888011
42. Thymocyte maturation is regulated by the activity of the helix-loop-helix protein, E47. G Bain MW Quong RS Soloff SM Hedrick C Murre, J Exp Med 1999 190 1605 16 10.1084/jem.190.11.1605 10587351
43. E2A and HEB Are Required to Block Thymocyte Proliferation Prior to Pre-TCR Expression. J Wojciechowski A Lai M Kondo Y Zhuang, J Immunol 2007 178 5717 26 17442955
44. Identification of residues in the estrogen receptor that confer differential sensitivity to estrogen and hydroxytamoxifen. PS Danielian R White SA Hoare SE Fawell MG Parker, Mol Endocrinol 1993 7 232 40 10.1210/me.7.2.232 8469236
45. Virus-transformed pre-B cells show ordered activation but not inactivation of immunoglobulin gene rearrangement and transcription. MS Schlissel LM Corcoran D Baltimore, J Exp Med 1991 173 711 20 10.1084/jem.173.3.711 1900081
46. Immunoglobulin heavy and light chain genes rearrange independently at early stages of B cell development. A Ehlich S Schaal H Gu D Kitamura W Muller K Rajewsky, Cell 1993 72 695 704 10.1016/0092-8674(93)90398-A 8453664
47. SoDA: implementation of a 3D alignment algorithm for inference of antigen receptor recombinations. JM Volpe LG Cowell TB Kepler, Bioinformatics 2006 22 438 44 10.1093/bioinformatics/btk004 16357034